Year To Quarter End Statement Of Income

Kringle Pharma,Inc. - Filing #7592098

Concept 2021-10-01 to
2022-06-30
2020-10-01 to
2021-06-30
Year to quarter end statement of income
Statement of income
Net sales
112,068,000 JPY
117,825,000 JPY
Cost of sales
JPY
JPY
Gross profit (loss)
112,068,000 JPY
117,825,000 JPY
Selling, general and administrative expenses
495,175,000 JPY
422,691,000 JPY
Selling, general and administrative expenses
Operating profit (loss)
-383,107,000 JPY
-304,865,000 JPY
Non-operating income
Non-operating income
85,774,000 JPY
82,578,000 JPY
Non-operating expenses
Non-operating expenses
8,387,000 JPY
22,890,000 JPY
Ordinary profit (loss)
-305,721,000 JPY
-245,177,000 JPY
Profit (loss) before income taxes
-305,721,000 JPY
-245,177,000 JPY
Income taxes - current
1,117,000 JPY
1,117,000 JPY
Income taxes
1,117,000 JPY
1,117,000 JPY
Profit (loss)
-306,838,000 JPY
-246,295,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.